Greater Than 95% Success with 14‐day Bismuth Quadruple Anti‐ Helicobacter pylori Therapy: A Pilot Study in US Hispanics

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Helicobacter

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1523-5378.2012.00962.xPMID 22967122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

  2012cited by this paper
• Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.

  2011cited by this paper
• Key Points for Designing and Reporting Helicobacter pylori Therapeutic Trials: A Personal View

  2011cited by this paper
• Double-blind Randomized Trial of Quadruple Sequential Helicobacter pylori Eradication Therapy in Asymptomatic Infected Children in El Paso, Texas

  2011cited by this paper
• Helicobacter pylori Prevalence and Circulating Micronutrient Levels in a Low-Income United States Population

  2011cited by this paper
• 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

  2011cited by this paper
• Understanding and Appreciating Sequential Therapy for HelicobacterpyloriEradication

  2011cited by this paper
• Helicobacter pylori Eradication and Change in Markers of Iron Stores Among Non–iron-deficient Children in El Paso, Texas: An Etiologic Intervention Study

  2011cited by this paper
• Helicobacter pylori eradication therapy research: Ethical issues and description of results.

  2010cited by this paper
• Bismuth‐Containing Quadruple Therapy as Second‐Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea

  2010cited by this paper
• Trends in Hospitalizations for Peptic Ulcer Disease, United States, 1998–2005

  2010cited by this paper
• Efficient identification and evaluation of effective Helicobacter pylori therapies.

  2009cited by this paper
• Evaluation of Brushing Cytology in the Diagnosis of Helicobacter pylori Gastritis

  2008cited by this paper
• A Report Card to Grade Helicobacter pylori Therapy

  2007cited by this paper
• Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences

  2007cited by this paper
• Point-of-care Helicobacter pylori urine antibody detection in a multi-ethnic adult population in the United States.

  2006cited by this paper
• Iron deficiency and Helicobacter pylori infection in the United States.

  2006cited by this paper
• Antimicrobial Resistance and Characterization of Helicobacter pylori Strains Isolated from Mexican Adults with Clinical Outcome

  2005cited by this paper
• Novel bismuth–metronidazole–tetracycline triple‐layer tablet for treatment of Helicobacter pylori

  2005cited by this paper
• Identificação do Helicobacter pylori pela citologia do escovado gástrico: comparação com o método histológico

  2005cited by this paper
• [Helicobacter pylori identification by brush gastric cytology: a comparison with histologic method].

  2005cited by this paper
• Practical Rapid, Minimally Invasive, Reliable Nonendoscopic Method to Obtain Helicobacter pylori for Culture

  2005cited by this paper
• Antral exfoliative cytology for the detection of Helicobacter pylori in the stomach.

  2005cited by this paper
• Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies

  2004cited by this paper
• Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.

  2004cited by this paper
• Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, North A

  2003cited by this paper
• Evaluation of invasive and non-invasive diagnostic modalities for Helicobacter pylori infection in children.

  2003cited by this paper
• Antibiotic Susceptibility Patterns of Helicobacter pylori Strains Isolated from Northeastern Mexico

  2002cited by this paper
• Validation of Spanish Language Dyspepsia Questionnaire

  2002cited by this paper
• Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.

  2001cited by this paper
• Inability to Noninvasively Diagnose Gastric Intestinal Metaplasia in Hispanics or Reverse the Lesion with Helicobacter pylori Eradication

  2001cited by this paper
• Comparison of endoscopic brush cytology with biopsy for detection of Helicobacter pylori in patients with gastroduodenal diseases.

  2001cited by this paper
• Simplified 13C-urea breath test for detection of helicobacter pylori infection

  2001cited by this paper
• Increasing Multidrug Resistance inHelicobacter pylori Strains Isolated from Children and Adults in Mexico

  2001cited by this paper
• Brush cytology: An adjunct to diagnostic upper GI endoscopy

  2001cited by this paper
• Simplified 13C-urea breath test for detection of Helicobacter pylori infection.

  2001cited by this paper
• Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States.

  2001cited by this paper
• Statistical considerations in the intent-to-treat principle.

  2000cited by this paper
• [Treatment of Helicobacter pylori infection. Whom to treat and with what?].

  2000cited by this paper
• Evaluation of endoscopy-based diagnostic methods for the detection of Helicobacter pylori.

  2000cited by this paper
• What is meant by intention to treat analysis? Survey of published randomised controlled trials

  1999cited by this paper
• Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection

  1997cited by this paper
• Epi info, version 6 : a word-processing, database, and statistics program for public health on IBM-compatible microcomputers

  1996cited by this paper
• Intention‐to‐treat analysis and the goals of clinical trials

  1995cited by this paper
• Helicobacter pylori in gastroduodenal diseases: Rapid identification by endoscopic brush cytology

  1993cited by this paper
• [The use of antibiotics in a community of Mexico City. I. A household survey].

  1993cited by this paper
• Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal Ulcer

  1992cited by this paper
• Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.

  1992cited by this paper
• Factors influencing the eradication of Helicobacter pylori with triple therapy.

  1992cited by this paper
• Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.

  1991cited by this paper

• Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection—Questions Focused on Clinical Practice

  2026cites this paper
• Co-Occurrence of Helicobacter pylori and Candida spp. Infections in the Pathogenesis of Gastrointestinal Diseases

  2025cites this paper
• Bismuth-based quadruple therapy versus standard triple therapy for the eradication of Helicobacter pylori in Belgium: a multicentre, non-blinded randomized, prospective study.

  2024cites this paper
• Consensus recommendations for the screening, diagnosis, and management of Helicobacter pylori infection in Hong Kong.

  2023cites this paper
• EVALUATION OF THE EFFICACY OF TWO DIFFERENT HELIOCOBACTER PYLORI ERADICATION REGIMENS AT A SECONDARY PUBLIC HEALTH CARE CENTER

  2023cites this paper
• İKİNCİ BASAMAK DEVLET HASTANESİNDE İKİ FARKLI HELICOBACTER PYLORI TEDAVİ REJİMİNİN ETKİNLİĞİNİN DEĞERLENDİRİLMESİ.

  2023cites this paper
• Helicobacter pylori diagnosis and therapy in the era of antimicrobial stewardship

  2021cites this paper
• High-dose dual therapy is effective as first-line treatment for Helicobacter pylori infection.

  2020cites this paper
• Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen

  2020cites this paper
• Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg)

  2020cites this paper
• Medical Management of Peptic Ulcer Disease

  2019cites this paper
• Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori

  2019cites this paper
• Empirical Helicobacter pylori rescue therapy: an 18‐year single‐centre study of 1200 patients

  2019cites this paper
• Helicobacter pylori Infection

  2019cites this paper
• Retrospective Analysis Confirms Tetracycline Quadruple as Best Helicobacter pylori Regimen in the USA

  2019cites this paper
• Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies

  2018cites this paper
• Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial

  2018cites this paper
• IVth Brazilian Consensus Conference on Helicobacter pylori infection

  2018cites this paper
• Eradication Rate of Helicobacter pylori on the US–Mexico Border Using the Urea Breath Test

  2018cites this paper
• Bismuth‐containing quadruple therapy versus concomitant quadruple therapy as first‐line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross‐sectional, comparative, open trial

  2018cites this paper
• IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION.

  2018cites this paper
• Limited effectiveness with a 10‐day bismuth‐containing quadruple therapy (Pylera®) in third‐line recue treatment for Helicobacter pylori infection. A real‐life multicenter study

  2017cites this paper
• Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies

  2017cites this paper
• A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter pylori

  2017cites this paper
• Efficacy of three‐in‐one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population

  2017cites this paper
• Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection

  2017cites this paper
• First-Line Treatment in the Eradication of Helicobacter Pylori: where are we now?

  2017cites this paper
• The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.

  2017cites this paper
• Helicobacter pylori Therapy

  2016cites this paper
• IV Spanish Consensus Conference on Helicobacter pylori infection treatment.

  2016cites this paper
• Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

  2016cites this paper
• Comparison Between Sequential Therapy and Modified Bismuth-Included Quadruple Therapy for Helicobacter pylori Eradication in Chinese Patients

  2016cites this paper
• IV Spanish Consensus Conference on Helicobacter pylori infection treatment.

  2016cites this paper
• Eficacia del tratamiento guiado por cultivo en la infección por Helicobacter pylori

  2016cites this paper
• An Update on the Treatment of Helicobacter Pylori Infection

  2015cites this paper
• Practical Aspects in Choosing a Helicobacter pylori Therapy.

  2015cites this paper
• How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.

  2015cites this paper
• Current Helicobacter pylori treatment in 2014.

  2015cites this paper
• RESPONSE TO FIRST- LINE QUADRUPLE AND SECOND-LINE QUADRUPLE H PYLORI ERADICATION THERAPY IN IRAQI PATIENTS WITH PEPTIC ULCER DISEASE

  2015cites this paper
• Antibiotic treatment for Helicobacter pylori: Is the end coming?

  2015cites this paper
• Peptic ulcer disease.

  2015cites this paper
• Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

  2015cites this paper
• First-line therapy in Helicobacter pylori eradication therapy: experience of a surgical clinic.

  2014cites this paper
• Practical treatment of Helicobacter pylori: a balanced view in changing times

  2014cites this paper
• PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

  2014cites this paper
• Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori

  2014cites this paper
• An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori

  2014cites this paper
• Treatment of Helicobacter pylori Infection 2013

  2013cites this paper
• How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

  2013cites this paper
• Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.

  2013cites this paper
• Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China

  2013cites this paper
• Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study

  2013cites this paper
• Which Treatment in Helicobacter pylori Infection

  2013cites this paper
• Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection

  2013cites this paper
• Eradication of Helicobacter Pylori: In Search of a Better Therapy

  2012cites this paper